Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar;89(1):157-168.
doi: 10.1007/s11126-017-9521-z.

Clozapine in Reducing Aggression and Violence in Forensic Populations

Kathleen Patchan  1 , Gopal Vyas  2 , Ann L Hackman  1 , Marie Mackowick  3 , Charles M Richardson  2 , Raymond C Love  4 , Ikwunga Wonodi  5 , MacKenzie A Sayer  5 , Matthew Glassman  5 , Stephanie Feldman  5 , Deanna L Kelly  6
Affiliations
Review

Clozapine in Reducing Aggression and Violence in Forensic Populations

Kathleen Patchan et al. Psychiatr Q. 2018 Mar.

Abstract

Popular media often portray people with a mental illness as being aggressive, violent, and incarcerated as a result of their behavior. Despite exaggeration in the media, risks for some aggressive behaviors are in fact higher in individuals with schizophrenia. This is often the case with influence of comorbid substance use disorders. It is essential that mental health professionals are aware of treatments that may help with attenuating and treating behaviors that contribute to violence, aggression and incarceration. This paper reviews violence and incarceration in individuals with schizophrenia as well as recommendations, guidelines and benefits for the use of clozapine in this population. Clozapine remains one of the most underutilized evidence-based medications available in the psychiatric arena in the United States. It is a viable and recommended option in the forensic population and it may be helpful on the path to recovery as well as bring substantial savings to the criminal justice system.

Keywords: Aggression; Clozapine; Criminal justice; Forensic; Violence.

PubMed Disclaimer

References

    1. Bortolato B, Miskowiak KW, Kohler CA, et al. Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses. Neuropsychiatr Dis Treat. 2015;11:3111–3125. - PMC - PubMed
    1. Carbon M, Correll CU. Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia. CNS Spectr. 2014;19(Suppl 1):38–52. quiz 35–37, 53. - PubMed
    1. Lysaker PH, Vohs J, Minor KS, et al. Metacognitive Deficits in Schizophrenia: Presence and Associations With Psychosocial Outcomes. J Nerv Ment Dis. 2015;203:530–536. - PubMed
    1. Bouwmans C, de Sonneville C, Mulder CL, et al. Employment and the associated impact on quality of life in people diagnosed with schizophrenia. Neuropsychiatr Dis Treat. 2015;11:2125–2142. - PMC - PubMed
    1. Brekke JS, Prindle C, Bae SW, et al. Risks for individuals with schizophrenia who are living in the community. Psychiatr Serv. 2001;52:1358–1366. - PubMed

Publication types

LinkOut - more resources